Literature DB >> 22828802

Sustained activation of N-methyl-D-aspartate receptors in podoctyes leads to oxidative stress, mobilization of transient receptor potential canonical 6 channels, nuclear factor of activated T cells activation, and apoptotic cell death.

Eun Young Kim1, Marc Anderson, Stuart E Dryer.   

Abstract

Atypical N-methyl-D-aspartate (NMDA) receptors are expressed in podocytes. Sustained (≥24 h) application of 50 to100 μM NMDA to immortalized mouse podocytes evoked a marked increase in the production of reactive oxygen species(ROS) such as H₂O₂. This effect of NMDA was associated with increased cell-surface expression of p47(phox), a cytosolic regulatory subunit of the NADPH oxidase NOX2. NMDA-evoked generation of ROS drove an increase in steady-state surface expression of transient receptor potential canonical (TRPC) 6 channels, which was blocked by the NMDA antagonist dizocilpine(MK-801) and by a membrane-permeable scavenger of ROS. The effect of NMDA on TRPC6 was observed using cell surface biotinylation assays and also with whole-cell recordings made under conditions designed to facilitate detection of current through TRPC6. NMDA mobilization of TRPC6 channels was blocked by concurrent treatment with the NMDA antagonist MK-801 and by a membrane-permeable scavenger ofROS. Mobilization of TRPC6 was also evoked by L-homocysteic acid. NMDA treatment also increased nuclear localization of endogenous nuclear factor of activated T cells, which could be blocked by MK-801, by scavenging ROS, by the calcineurin inhibitor cyclosporine, and by the TRPC channel inhibitor 1-[2-(4-methoxyphenyl)-2-[3-(4-methoxyphenyl)propoxy]ethyl]imidazole (SKF-96365). NMDA treatment also evoked robust activation of Rho but not Rac,consistent with previous studies of downstream effectors of TRPC6 activation. Exposing cells to NMDA for 24 h reduced total and cell surface expression of the podocyte markers nephrin and podocin, but there was no loss of cells. With longer NMDA exposure (72 h), we observed loss of cells associated with nuclear fragmentation and increased expression of caspase-3, caspase-6, and Bax, suggesting an apoptotic process.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22828802      PMCID: PMC3463221          DOI: 10.1124/mol.112.079376

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  59 in total

1.  Serum homocysteine levels are associated with the development of (micro)albuminuria: the Hoorn study.

Authors:  A Jager; P J Kostense; G Nijpels; J M Dekker; R J Heine; L M Bouter; A J Donker; C D Stehouwer
Journal:  Arterioscler Thromb Vasc Biol       Date:  2001-01       Impact factor: 8.311

Review 2.  Therapy of hyperhomocysteinemia in chronic kidney disease.

Authors:  Ziad A Massy
Journal:  Semin Nephrol       Date:  2006-01       Impact factor: 5.299

Review 3.  The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology.

Authors:  Karen Bedard; Karl-Heinz Krause
Journal:  Physiol Rev       Date:  2007-01       Impact factor: 37.312

4.  TRPC6 fulfills a calcineurin signaling circuit during pathologic cardiac remodeling.

Authors:  Koichiro Kuwahara; Yanggan Wang; John McAnally; James A Richardson; Rhonda Bassel-Duby; Joseph A Hill; Eric N Olson
Journal:  J Clin Invest       Date:  2006-11-09       Impact factor: 14.808

5.  Glomerular podocytes contain neuron-like functional synaptic vesicles.

Authors:  Maria Pia Rastaldi; Silvia Armelloni; Silvia Berra; Novella Calvaresi; Alessandro Corbelli; Laura Anna Giardino; Min Li; Guo Quin Wang; Alessandro Fornasieri; Antonello Villa; Eija Heikkila; Rabah Soliymani; Anissa Boucherot; Clemens David Cohen; Matthias Kretzler; Almut Nitsche; Maddalena Ripamonti; Antonio Malgaroli; Marzia Pesaresi; Gian Luigi Forloni; Detlef Schlöndorff; Harry Holthofer; Giuseppe D'Amico
Journal:  FASEB J       Date:  2006-04-03       Impact factor: 5.191

6.  Homocysteine or renal impairment: which is the real cardiovascular risk factor?

Authors:  Kathleen Potter; Graeme J Hankey; Daniel J Green; John W Eikelboom; Leonard F Arnolda
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-03-20       Impact factor: 8.311

7.  Podocyte injury and glomerulosclerosis in hyperhomocysteinemic rats.

Authors:  Fan Yi; Elisabete A dos Santos; Min Xia; Qi-Zheng Chen; Pin-Lan Li; Ningjun Li
Journal:  Am J Nephrol       Date:  2007-03-30       Impact factor: 3.754

8.  Nephrin binds to the COOH terminus of a large-conductance Ca2+-activated K+ channel isoform and regulates its expression on the cell surface.

Authors:  Eun Young Kim; Kyoung-Jae Choi; Stuart E Dryer
Journal:  Am J Physiol Renal Physiol       Date:  2008-05-14

9.  NMDA receptor activation increases free radical production through nitric oxide and NOX2.

Authors:  Helene Girouard; Gang Wang; Eduardo F Gallo; Josef Anrather; Ping Zhou; Virginia M Pickel; Costantino Iadecola
Journal:  J Neurosci       Date:  2009-02-25       Impact factor: 6.167

10.  The actin cytoskeleton of kidney podocytes is a direct target of the antiproteinuric effect of cyclosporine A.

Authors:  Christian Faul; Mary Donnelly; Sandra Merscher-Gomez; Yoon Hee Chang; Stefan Franz; Jacqueline Delfgaauw; Jer-Ming Chang; Hoon Young Choi; Kirk N Campbell; Kwanghee Kim; Jochen Reiser; Peter Mundel
Journal:  Nat Med       Date:  2008-09       Impact factor: 53.440

View more
  16 in total

1.  TRPC5 Does Not Cause or Aggravate Glomerular Disease.

Authors:  Xuexiang Wang; Ranadheer R Dande; Hao Yu; Beata Samelko; Rachel E Miller; Mehmet M Altintas; Jochen Reiser
Journal:  J Am Soc Nephrol       Date:  2017-10-23       Impact factor: 10.121

2.  Transmembrane insertases and N-glycosylation critically determine synthesis, trafficking, and activity of the nonselective cation channel TRPC6.

Authors:  Brianna E Talbot; David H Vandorpe; Brian R Stotter; Seth L Alper; Johannes S Schlondorff
Journal:  J Biol Chem       Date:  2019-07-02       Impact factor: 5.157

3.  Estradiol mitigates ischemia reperfusion-induced acute renal failure through NMDA receptor antagonism in rats.

Authors:  Amrit Pal Singh; Nirmal Singh; Preet Mohinder Singh Bedi
Journal:  Mol Cell Biochem       Date:  2017-04-21       Impact factor: 3.396

4.  High glucose induces podocyte apoptosis by stimulating TRPC6 via elevation of reactive oxygen species.

Authors:  Bing-Chen Liu; Xiang Song; Xiao-Yu Lu; Daniel T Li; Douglas C Eaton; Bao-Zhong Shen; Xue-Qi Li; He-Ping Ma
Journal:  Biochim Biophys Acta       Date:  2013-03-13

5.  Lovastatin inhibits human B lymphoma cell proliferation by reducing intracellular ROS and TRPC6 expression.

Authors:  Xiang Song; Bing-Chen Liu; Xiao-Yu Lu; Li-Li Yang; Yu-Jia Zhai; Amity F Eaton; Tiffany L Thai; Douglas C Eaton; He-Ping Ma; Bao-Zhong Shen
Journal:  Biochim Biophys Acta       Date:  2014-02-08

6.  NMDA Receptors as Potential Therapeutic Targets in Diabetic Nephropathy: Increased Renal NMDA Receptor Subunit Expression in Akita Mice and Reduced Nephropathy Following Sustained Treatment With Memantine or MK-801.

Authors:  Hila Roshanravan; Eun Young Kim; Stuart E Dryer
Journal:  Diabetes       Date:  2016-07-07       Impact factor: 9.461

7.  Expression of Glutamate Receptor Subtype 3 Is Epigenetically Regulated in Podocytes under Diabetic Conditions.

Authors:  Zhengzhe Li; Haibing Chen; Fang Zhong; Weijia Zhang; Kyung Lee; John Cijiang He
Journal:  Kidney Dis (Basel)       Date:  2018-10-26

8.  Prevention of PKG1α oxidation augments cardioprotection in the stressed heart.

Authors:  Taishi Nakamura; Mark J Ranek; Dong I Lee; Virginia Shalkey Hahn; Choel Kim; Philip Eaton; David A Kass
Journal:  J Clin Invest       Date:  2015-05-04       Impact factor: 14.808

Review 9.  Role of NADPH oxidase-mediated reactive oxygen species in podocyte injury.

Authors:  Shan Chen; Xian-Fang Meng; Chun Zhang
Journal:  Biomed Res Int       Date:  2013-11-11       Impact factor: 3.411

10.  Angiotensin II has acute effects on TRPC6 channels in podocytes of freshly isolated glomeruli.

Authors:  Daria V Ilatovskaya; Oleg Palygin; Vladislav Chubinskiy-Nadezhdin; Yuri A Negulyaev; Rong Ma; Lutz Birnbaumer; Alexander Staruschenko
Journal:  Kidney Int       Date:  2014-03-19       Impact factor: 10.612

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.